Agaricus Blazei Research

[Antimutagenic and bactericidal substances in the fruit body of a Basidiomycete Agaricus blazei, Jun-17]

Yakugaku Zasshi 1994 May;114(5):342-50

 

[Article in Japanese]
Osaki Y, Kato T, Yamamoto K, Okubo J, Miyazaki T
Tokyo College of Pharmacy, Japan.

The fruit body of a Basidiomycete Agaricus blazei, Jun-17 (Himematsutake) was extracted with hexane and chloroform-methanol (2:1, v/v), and the antimutagenic effect of the extracts was examined using an Ames/Salmonella/microsome assay. Both extracts of Agaricus inhibited the mutagenicity of benzo[a]pyrene(B[a]P). The hexane extract was purified by silica gel column chromatography and high performance liquid chromatography (HPLC), and linoleic acid was isolated as a main substance having antimutagenic activity. Fr. IIa, IIb, IIc and IIb, which reduced the number of His+ revertant colonies induced by B[a]P, were separated from the chloroform-methanol extract by silica gel column chromatography and HPLC. An antimutagenic substance in Fr. IIa was linoleic acid. From Fr. IIb, a bactericidal, not antimutagenic, substance was isolated and identified as 13-hydroxy cis-9, trans-11-octadecadienoic acid (13ZE-LOH). Antimutagenic substances in Fr. IIc and IId were not purified. The possible source and mechanism of formation of 13ZE-LOH are discussed.

PMID: 8014843, UI: 94285038

 

Table of Contents

 

bookmark image

Bookmark this page into your favorite bookmark manager. Or press (CTRL-D)


NOTE: Regardless of how our products are used in other countries, or anything that you may have heard or read, under FDA law in the United States, it is illegal for a manufacturer to make any medical claims for health supplements. None of the products offered for sale on this website have been evaluated by the FDA. All statements made by Aloha Medicinals Inc. are intended for informational purposes only. Our products are not intended to diagnose, treat, cure or prevent any disease. Health decisions are much too important to be made without the advice of a health care practitioner. We invite and encourage you to share this information with your doctor. We are happy to share our research materials with anyone who asks.